Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 2 |
2020 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
LAPTM5-CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance.
Front Oncol. 2020 Jun 5;10:747. doi: 10.3389/fonc.2020.00747. eCollection 2020.
Front Oncol. 2020.
PMID: 32582531
Free PMC article.
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma.
Berberich A, Schmitt LM, Pusch S, Hielscher T, Rübmann P, Hucke N, Latzer P, Heßling B, Lemke D, Kessler T, Platten M, Wick W.
Berberich A, et al. Among authors: hucke n.
J Neurooncol. 2020 Jan;146(1):9-23. doi: 10.1007/s11060-019-03348-z. Epub 2019 Nov 28.
J Neurooncol. 2020.
PMID: 31776900
Item in Clipboard
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib.
Berberich A, Kessler T, Thomé CM, Pusch S, Hielscher T, Sahm F, Oezen I, Schmitt LM, Ciprut S, Hucke N, Ruebmann P, Fischer M, Lemke D, Breckwoldt MO, von Deimling A, Bendszus M, Platten M, Wick W.
Berberich A, et al. Among authors: hucke n.
Clin Cancer Res. 2019 Jan 1;25(1):253-265. doi: 10.1158/1078-0432.CCR-18-1580. Epub 2018 Oct 1.
Clin Cancer Res. 2019.
PMID: 30274984
Item in Clipboard
Cite
Cite